Pre-IPO Token Risks That Could Cost You Everything and How to Avoid Them

[nihalsari]

The appeal of pre-IPO tokens is straightforward: get exposure to SpaceX, Anthropic, or OpenAI before they go public and potentially capture the valuation jump that follows a listing. The risks are less straightforward and considerably more varied than most retail investors realize before they buy. Company disapproval risk is one of the most serious and least discussed. OpenAI publicly rejected Robinhood's tokenized offering, stating it did not represent OpenAI equity, that OpenAI was not involved, and that the company did not endorse the product. This precedent applies to any pre-IPO token operating without explicit company consent, which covers most of the products in this category.

Liquidity risk is the second major concern. Thin order books mean a position that shows gains on paper may be very difficult to exit without significant slippage. Anthropic-linked tokens on Jupiter have traded at implied valuations above $850 billion against an official post-money valuation of $380 billion, a gap that reflects speculation rather than fundamentals. Redemption risk adds another layer: some platforms explicitly state that settlement is not guaranteed and depends on liquidity and market demand at the time you want to exit. Before buying any pre-IPO token, a practical five-step checklist applies to every purchase: verify the issuer, check whether the token has real backing or only synthetic exposure, check trading volume before assuming you can exit, check whether redemption exists and under what conditions, and check whether the company actually endorses the product.

[madmax]

The irony is that leverage via perps is the worst structure for a thesis that depends on an IPO that could be 2–5 years away — theta and liquidation will eat you alive.